4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-145549
CIK 0001660719operating
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:57 PM ET
Size
7.4 KB
Accession
0001104659-16-145549
Insider Transaction Report
Form 4
Harris Robert Paul
Director
Transactions
- Sale
Common Shares, without par value
2016-09-15$5.60/sh−75,000$420,000→ 669,094 total
Holdings
- 600,188(indirect: By Spouse)
Common Shares, without par value
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2016.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.00 to $6.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:57 PM ET
- Size
- 7.4 KB